November 21, 2025 • 37 mins
Watch Paul LIVE every day on YouTube: http://bit.ly/3vTiACF.
Hosts: Paul Sweeney and Scarlet Fu
On this podcast:
- Kunjan Sobhani, Bloomberg Intelligence Senior Semiconductor Analyst, recaps Nvidia earnings.
- Mandeep Singh, Global Tech Research Head at Bloomberg Intelligence, discusses Microsoft and Nvidia investing up to $15 billion in Anthropic.
- Jennifer Bartashus, Bloomberg Intelligence Senior Analyst, Retail Staples & Packaged Food, discusses Walmart earnings.
- Drew Reading, Bloomberg Intelligence U.S Homebuilding Analyst, recaps Lowe’s earnings.
- Anthony Hughes, Bloomberg US ECM Reporter, recaps Klarna earnings.
- Michael Shah, Bloomberg Intelligence Senior Pharma-Biotech Analyst, discusses Novo Nordisk undercutting Eli Lilly’s obesity drug price for cash-pay patients.
- Mary Ross Gilbert, Bloomberg Intelligence, Senior Equity Analyst, Covering Retail, recaps TJX earnings.
- Abigail Gilmartin, Bloomberg Intelligence Athleisure and Footwear Analyst, recaps Amer Sports earnings.
Bloomberg Intelligence, the research arm of Bloomberg L.P., has more than 400 professionals who provide in-depth analysis on more than 2,000 companies and 135 industries while considering strategic, equity and credit perspectives. BI also provides interactive data from over 500 independent contributors. It is available exclusively for Bloomberg Terminal subscribers.
See omnystudio.com/listener for privacy information.
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Bloomberg Audio, Studios, podcasts, radio news. This is Bloomberg Intelligence
with Scarletfoo and Paul Sweeney.
Speaker 2 (00:13):
How do you think the FED is looking at tariffs?
The uncertainty of terriffs.
Speaker 3 (00:17):
Let's take a look at the sectors and how.
Speaker 2 (00:19):
They performed a lot of investors getting whip saled every
day by news events.
Speaker 1 (00:22):
Breaking market headlines and corporate news from across the globe.
Speaker 3 (00:26):
Could we see a market disruption of market events?
Speaker 2 (00:28):
So people just too exuberant out there?
Speaker 3 (00:31):
You see some so called low quality stocks driving this
short term rally.
Speaker 1 (00:34):
Bloomberg Intelligence with Scarletfoo and Paul Sweeney on Bloomberg Radio,
YouTube and Bloomberg Originals.
Speaker 2 (00:42):
On today's Bloomberg Intelligence Show, we dig inside the big
business story is impacting Wall Street and the global markets.
Speaker 3 (00:47):
Each and every week we provide in depth research and
data on some of the two thousand companies and one
hundred and thirty industries are analysts covered worldwide.
Speaker 2 (00:53):
Today, we'll look at earnings reports from some of the
world's largest retailers.
Speaker 3 (00:57):
Plus look at why the Danish drug maker Novo Nordisk
will be further lowering the prices of its obesity drugs
for cash paying patients first.
Speaker 2 (01:03):
We'll begin with earnings from chip Giant and Video.
Speaker 3 (01:06):
This week, the company reported third quarter earnings that topped
analyst estimates, and Vidia also delivered a surprisingly strong revenue
forecast and pushback on the idea that the AI industry
is in a bubble.
Speaker 2 (01:16):
For more, we were joined by Kunjohn Sabani, Bloomberg Intelligence
Senior Semiconductor analyst. We first asked Kunjohn for his take
on in Vidia this week.
Speaker 4 (01:24):
This was one of the more bullish earnings we have
seen from this name in a while, not just on
the numbers of the three Q four Q guide, which
they blew past even the loftiest Byside targets, but just
beyond that the long term the twenty six sort of
and going into twenty seven demands signals that they showed,
namely the half a trillion of the pipeline, which we
(01:46):
think now is a conservative number given the number of
deals they have announced. If supply keeps on coming up
as it has, and if their customers continue executing on
these bills without any missteps, we think their significant upside
to the current numbers.
Speaker 3 (02:01):
Yeah, just looking through the numbers, clearly a beaten Rais report,
but you know, the scale at which it can be
in race is impressive. Although within the third quarter numbers,
I did see that chips used in gaming PCs missed
analess estimates, and I know that that's a shrinking part
of the business, or at least it's not as big
a part of the business, given that the data center
is where the growth is really at. Are there any
(02:24):
flaws in this earnings report? Conjohn?
Speaker 4 (02:26):
Not really? I mean, look, the gaming is becoming so
unimportant for analysts that the reliability of the predictability of
those numbers against which we are comparing the bet and
miss for gaming is no longer as reliable. So no
real flaws to really point out in this. We did
see their supply commitments go up quarter work quarter and
(02:47):
inventory is rising. I don't think that's a negative. While
it might seem on the face that's just them getting
up and getting ready for that next wave to supply
the chips in the next year.
Speaker 2 (02:57):
So could John what's the latest and Gentin want about
how he've used China going forward?
Speaker 4 (03:03):
Nothing has changed on the China side. They still don't
assume any revenues when it comes to data center AI
China GPUs or the H twenty has been shipped into
They do have the clearance licenses so they could, but
it seems because of the geopolitical issues, China has basically
been shut down for American GPU providers or AC providers
to be able to ship in the country. There isn't,
(03:25):
to be honest, no demand. So it seems, you know,
because of geopolitical issues, the customers in China are not
just reading and getting up to buy in media chips
right now.
Speaker 3 (03:34):
Jensenhang said that he from his vantage point, does not
see anything like an AI bubble. We see something very different,
and he says competitive pressures remain fairly low because this
is a company with more than ninety percent of the
market for those high end super fast AI chips. Who
is the closest competitor if there is one t Invidia.
Speaker 4 (03:55):
Yeah, in terms of the size of the markets, the
next closest competitor would be the AIA six chips, So
Broadcome is one of the biggest providers of AI six chips,
namely the TPU that Google uses. Another example would be
Amazon's Treanium chips, which are on different AI asic designers supply.
So in terms of revenues, or units in terms of
(04:16):
the market that those are the next closest competitors within
Nvidia's realm, which it sells merchant gipus, AMD would be
the second closest competitor in that our Thanks.
Speaker 3 (04:26):
To Kunjan Sabani, Bloomberg Intelligence Senior semiconductor analyst.
Speaker 2 (04:29):
We continue in the tech space.
Speaker 3 (04:31):
This week we heard that the tech giants Microsoft and
Nvidia are committing to invest up to a combined fifteen
billion dollars in the AI research and development company Anthropic.
Speaker 2 (04:40):
We heard the investment will be part of anthropics next
funding round. The companies also said Anthropic has committed to
purchase thirty billion dollars of computing capacity for Microsoft's Azure
cloud service.
Speaker 3 (04:50):
So of course we had to enlist. Mandeep Singh, global
tech research head at Bloomberg Intelligence.
Speaker 2 (04:55):
First asked man Deep to tell us a little more
about Anthropic and what it does well.
Speaker 5 (04:59):
Anthropic is one of the five frontier lms that are remaining,
I mean, and they are leading the charge when it
comes to generative AI. So it's one of the five.
The other one are Google, Open Ai, Meta and XAI.
And so look, when it comes to these commitments, it's
(05:19):
pretty obvious that open Ai has raised the bar by
announcing they're going to spend one point four trillion. So
the question is what are the other LLM companies going
to do? And Entropic is also a pure play LLLM,
and in their case, they don't have the funding. I mean,
they don't have the balance sheet like Google or Meta have,
(05:40):
so they have to raise the money either in the
private markets or from someone like Nvidia, or get into
an agreement with Microsoft, which also has an agreement with
open Ai. So that's where you know. Llms need compute.
That's how you serve billion plus users, and that's where
you know the numbers get bigger and bigger when it
(06:02):
comes to the tie ups with cloud provider.
Speaker 3 (06:04):
This is like the popular click in high school, where
everyone knows each other and everyone's messing around with each other.
Just give us a little bit of background here on Anthropic,
because my understanding is that it was founded by folks
who used to work at open Ai and some of
the early investors like big stakeholders include Alphabet and include
Amazon and now you've got Microsoft in there. I mean,
(06:27):
is there anyone who's not part of Anthropic and not
committed to investing in this company.
Speaker 5 (06:32):
Well, you could say Meta, they're doing things.
Speaker 3 (06:36):
They're doing their own thing.
Speaker 5 (06:37):
They are doing their own thing in terms of, you know,
using the computer internally, and they don't have a cloud business.
Speaker 3 (06:44):
Is that a problem for them that Meta's out there
on its own I know, it doesn't have its own
cloud business, but it's not buying stakes or committed to
invest up to five billion or ten billion in any
of these AI companies.
Speaker 5 (06:55):
I mean so far, just to go to Meta, it
feels like, you know, investors were okay with them using
the GPU compute for their own family of apps. But
the fact that they're talking about one hundred billion plus
in capex for next year without having a substantial ROI
and what I mean by rois in the case of Microsoft,
(07:15):
yes they're raising their CAPEX two hundred and twenty billion,
but they're winning deals like the one with Nthropic thirty
billion dollar in commitment from Entropic, so somebody is paying
for that compute. In the case of Microsoft, you don't
have that with a Meta. How are you generating ROI
outside of your family of apps? And over there you
(07:36):
have to show a really substantial increase in engagement to
convince investors it's worth hundred billion plus in capex.
Speaker 2 (07:43):
Any of these open aies anthropics, are they going to
ever come public? Do you think?
Speaker 5 (07:49):
I mean, in the case of Entropic, look, I know
the numbers are getting big, but their gross margins at
this point are probably better than open AI, which is
doing too much any things. I mean, the biggest risk
I see for Opening Eyes they feel they can get
into any business, whether it's chip business, whether it's you know,
(08:09):
obviously LLLM is their turf, any type of applications, and
that's where there's a possibility of a misstep. You can
end up wasting time because you just don't have, uh,
you know, the capability. Yeah, the focus Entropic is more.
Speaker 3 (08:23):
Focused our thanks Toman deep saying, global tech research head
at Bloomberg Intelligence.
Speaker 2 (08:28):
We move next to some earnings from some of the
world's largest retailers.
Speaker 1 (08:31):
This week.
Speaker 3 (08:32):
Target posted a drop in third quarter sales due to
intense competition and a weakening economy, with shoppers pulling back
on apparel and home goods.
Speaker 2 (08:39):
Separately, Walmart reported third quarter earnings that beat analysts expectations.
The retailer also increased its outlook for sales in the
full year. It's a sign Walmart is winning over priced
sensitive shoppers while digesting costs it expects to rise in
the coming months.
Speaker 3 (08:53):
For more, we were joined by Jennifer bartashis Bloomberg Intelligence
senior analysts covering retail staples and packaged foods.
Speaker 2 (08:58):
First test jenf for her take on the most recent
results at Walmart.
Speaker 6 (09:02):
You know, Walmart had another good quarter, and I think
that it's very easy to attribute a lot of their
success to just the value seeking behavior of consumers in
this environment. But I think that would also be overlooking
a lot of the investments they've made in things like
convenience that is really spurring the e commerce growth. And
that was really a notable takeaway.
Speaker 3 (09:20):
Yeah, that e commerce aspect helps draw on higher income shoppers,
so it's a larger pool of customers at Walmart now
has access to and in our Bloomberg News reporting we
indicate that the digital offerings now include luxury items like
pre owned Chanel bags. I had no idea that that
kind of stuff was available on walmart dot com.
Speaker 6 (09:39):
Well, you know, Walmart has done a lot to really
expand its marketplace, and that includes bringing in items that
you know, will appeal to that higher income consumer, you know,
And the tactic behind all of this is that the
more people are integrated with e commerce in going to stores,
they become sticky and they become loyal customers, so that
when the macre can comic backdrop fades, it really increases
(10:02):
Walmart's ability to hang onto these customers going forward, and
that just drives future growth. So it's a really interesting
play out of how they're applying that tactic.
Speaker 3 (10:11):
Jen, I also want to get your take on Walmart transferring.
It's listing to the NASAC that's going to happen on
December ninth, and that of course is to reflect as
focus on being a tech forward company. But I'm wondering,
I mean, how much of this is really just about
being included in the Nazak one hundred and therefore the
qqq etl Oh.
Speaker 6 (10:30):
Yeah, there's certainly part of that scarlet where you know,
that's that's probably part of the motivation. I think that
there is. You know, obviously there's a perception with regards
to being perceived more as a tech company, which Walmart
in all truthfulness, has evolved into a tech company, especially
amongst other retailers. By being listed at NASDAK, you know,
(10:51):
long term, maybe it helps their valuation, you know, just
in terms of having that perception of being more you know,
aligned with peers. You know, Amazon listed on Nasdaq, things
like that. So I think that there's a lot of
those components together combined, are really behind the move.
Speaker 2 (11:08):
Jen nobody arguably has a better finger on the pulse
of the consumer than Walmart. What are they saying these days?
Speaker 6 (11:14):
Actually, they seem relatively optimistic. You know, they talk about
you know, spending, holding study for kind of that middle
income consumer, high end consumer seemed to be spending pretty freely,
a little bit of concern about some of the lower
end consumer, but it does seem to be sort of
evening out. And so when they were looking forward to
the holiday season, which is you know, the most important
(11:35):
thing with regards to the retailers that I cover, they
seem cautiously optimistic that there will be a pretty good
holiday season this year. We do think that they're going
to people will prioritize spending on kids. That's usually what
happens first if they're holding back in other parts of
their budget. But all indicators right now seem that we're
headed towards a reasonably solid holiday season.
Speaker 3 (11:56):
Are thanks to Jennifer Bartash's Bloomberg Intelligence senior analysts covering retail,
staples and packaged food. Coming up, we'll take a look
at why the global payments services provider Klarna reported record
revenue in its first quarter since going public.
Speaker 2 (12:08):
You're listening to Bloomberg Intelligence on Bloomberg Radio, providing in
depth research and data on two thousand companies and one
hundred and thirty industries.
Speaker 3 (12:14):
You can access Bloomberg Intelligence via Bigo on the terminal.
I'm Scarlet Foo and.
Speaker 2 (12:18):
I'm Paul Sweeney, and this is Bloomberg.
Speaker 1 (12:24):
This is Bloomberg Intelligence with Scarlet Foo and Paul Sweeney
on Bloomberg Radio.
Speaker 2 (12:31):
We move next to earnings from some of the world's
largest home improvement retailers.
Speaker 3 (12:35):
This week, Low's reported third quarter profit that topped analyst estimates.
This was a result of online sales and demand from
professional contractors.
Speaker 2 (12:42):
Separately, we heard from Home Depot, who cut its full
of your guidance. This come as a company warned that
some unsteady consumers are hitting the pause button on big
ticket home purchases.
Speaker 3 (12:50):
So we spoke with Drew Redding Bloomberg Intelligence US home
building analyst.
Speaker 2 (12:54):
We first Saske Drew to break down this week's results
from Low's and how they compare it to Home Depots.
Speaker 7 (12:58):
So, I think Loew's result could be best characterized as
better than feared, particularly in light of what we heard
from Home Depot. They did fall short of consensus estimates
on same store sales, but I think the buy side
was probably looking for something flat to lower, so a
little bit better than they were looking for. Now that
being said, they did trim their four year outlook. Now
(13:21):
they're looking for four year comp sales to be flat
from flat to up one percent, So that would imply
that four Q is relatively flat. But you know, similar
to what we heard from Home Depot, they had about
one hundred basis point impact from hurricane activity that was
not replicated this year. So again, if you were to
back that out, it looks like the underlying trends in
the business are pretty stable.
Speaker 5 (13:43):
You know.
Speaker 7 (13:43):
That being said, they're still grappling with the same consumer
uncertainty and you know, the same weak housing market that
their competitors, so you know, still challenges out there in
the market.
Speaker 2 (13:53):
Drew, I think I understand it. Correctly that Lows has
a lower percentage of sales to professional contractors than does
Home Depot If so, are they trying to narrow the gap?
Are they targeting that segment a little more?
Speaker 7 (14:05):
Yeah, great question. So Low's is about thirty percent professional
contractors seventy percent DIY. Home Depot is about fifty to
fifty maybe even a little bit higher on the pro front.
What's interesting, and to your point on investment, is the
pro space, especially in building products distribution, has really become
a battleground among home improvement retailers. You had Home Depot
(14:28):
recently do acquisitions for srs and gms, and then you
have Lows who recently acquired foundation building materials, So it's
certainly an area where they're making a concerted effort to grow. Now.
Lows has historically focused on the small and medium sized
pro and what this acquisition does is it gives them
(14:48):
exposure to larger pros who do more complex projects, so
they're able to be the supplier of choice across more
building product categories and at a larger scale.
Speaker 3 (15:00):
So basically directly competing with Home DEEPO in many ways.
Is this going to become a duopoly or are there's
still a lot of other places that professional contractors can
go to.
Speaker 7 (15:10):
Yeah, so the building products distribution space is still very
highly fragmented, you know, I wouldn't be surprised to see
further consolidation within the industry, you know, across different categories.
Home Depot and Lows are certainly, you know, two of
the behemoths in the industry who have, you know, the
scale and financial flexibility to further consolidate the industry. But
(15:31):
there's some other players as well, like QXO. So it
is a mented industry, but I would expect, you know,
in the coming years, it's something that continues to get consolidated.
Speaker 2 (15:41):
I can't keep track of where all the tariffs are
these days on all the different products, but I'm just
guessing if I'm a Low's or Home Depot, my plywood
from Canada that's probably being tariff A power tool from
somewhere in Asia that's probably subject to tariff's. How are
these companies dealing with it? What have they been telling
you guys?
Speaker 7 (15:58):
So, Lows gets about sixty percent of its products from
the US, so their exposure internationally is maybe not as
high as you would expect. China's probably around fifteen to
twenty percent. You know, there hasn't been a whole lot
of talk. I think we have seen their average ticket
increase this quarter was up about three percent, and part
of that is in response to tariff related price increases.
(16:19):
Loose told us that they were only modest increases, and
you know, they'll take a portfolio approach to how they
increase prices. They'll look at their product line up and
see where they have more elasticity. But I think the
impact of costs will start to come in a little
greater as we look into Q four in early twenty
twenty six. And you know some of the areas that
we're looking at. You mentioned plywood so lumber tariffs from Canada.
(16:41):
We also had the implementation of tariffs on cabinetry both
the kitchen and bath, which to go up to fifty
percent in January. So I do think that the impact
gets a little greater as we look at the next year.
So I would expect further price increases from both retailers.
Speaker 3 (16:56):
Are Thanks to Drew Reading Bloomberg Intelligence, US home building analyst.
Speaker 2 (16:59):
We've moved to third quarter earnings from the global payment
services provider Klina this week.
Speaker 3 (17:04):
Kliner reported record revenue that beat analysts estimates on Wall Street.
The firm also set aside more provisions for credit losses
in its first set of earnings since going public.
Speaker 2 (17:12):
For more, I was joined by Anthony Hughes, Bloomberg Equity
Capital Markets reporter. I first asked Anthony to talk to
us about Cliner's most recent results.
Speaker 8 (17:20):
Yeah, Well, klan is a company that's actually been around
for about two decades. It's just that since about twenty
and nineteen they've really expanded quickly in.
Speaker 2 (17:28):
The US and by now.
Speaker 8 (17:29):
Pay Later is a lending slash payments product which basically
allows people to buy products and obviously pay for them
over time. And this is an alternative to the credit
card in a credit card option. So really a lot
of Klana's growth really reflects the fact that this product's
becoming more popular relative to credit cards and for a
(17:50):
lot of consumers, it's a good way to manage your
cash flow and you know, obviously buy a product and
not have to pay for over time, and that suits
a lot of people, and it is a fast growing
part of the fintech or say consumer lending space.
Speaker 2 (18:02):
And as a consumer, how does Clorina make money on
my one hundred dollars purchase that they put on their system. Yeah,
well they trudge me interest.
Speaker 8 (18:12):
No, well, this number of different products that some of
the longer term lending products do have interests associated with them.
But that paying for product they talk about, which is
paying in four installments over a few months, that is
an interest free product. And really the source of revenue
in this in that instance is from the merchant, and
merchants pay merchant service fee. It's high for them, it's
(18:32):
higher than they pay on a credit card transaction. But
basically they see the benefit of Klana bringing in extra
customers so they can sell more product. And you know,
people will ask themselves, well, who actually pays the merchant
service fee? While the merchant does pay that to Klana,
but the merchant does incorporate that as a cost of
doing business into the products that these sells to you
and I. So we in the sense we all pay
(18:55):
for the fees that are hidden within the payment system
and really merchants passed on to the consumer depending on
how you pay the interesting you pay for.
Speaker 2 (19:05):
Your who's a typical Klarner consumer out there? Like what
what's and what's kind of a typical transaction for a
buy nine.
Speaker 8 (19:12):
Yeah, well, these are mainly small transactions of you know,
can be a few hundred dollars or you know, not
not not large transactions. And and you know, this obviously
suits a younger audience, and that's where a lot of
the you know, a lot of their customer bases come from.
But they've built a large business which globally has something
like one hundred and ten billion of what they call
(19:33):
gross merchandise volume, and that's you know, it's a fast
growing business in the US. It's been growing pretty fast
for them, forty fifty percent in this recent quarter. And
obviously there's a couple of other companies that are in
this area as well, so it's a competitive area as well,
with a firm which is another company went public perhaps
about five years ago.
Speaker 3 (19:51):
That was Anthony Hughes, Bloomberg Equity Capital Markets Reporter.
Speaker 2 (19:54):
We moved to some news in the biotech space this week.
Speaker 3 (19:57):
We heard that the Danish drug maker Novo Nordesk will
be further lowering the prices of its obesity drugs for
cash paying patients.
Speaker 2 (20:03):
It's in an effort to call back a larger share
of the US market from arch rival Eli Lilly. Nova
said introductory doses of its blockbuster drugs we Govi and
ozembic will be available for one hundred and ninety nine
dollars a month.
Speaker 3 (20:15):
That price applies to the first two months of treatment.
After that, Nova will offer the drugs through its Novocare
direct to consumer portal for three hundred and forty nine
dollars a month, that is thirty percent less than the
current self pay price.
Speaker 2 (20:26):
For more, we were joined by Michael Shaw, Bloomberg Intelligence
Senior pharma biotech analyst. Well first asked Michael to break
down what exactly Nova nord Disk is doing.
Speaker 9 (20:35):
And this is obviously ahead of the White House tales.
So you're seeing starting dice is being reduced two hundred
dollars per month and then doses thereafter being charged at
an average of three hundred and fifty dollars per month
compared to five hundred dollars previously. So, I mean, you know,
those prices kind of align to, you know, the pricing
in the White House statement coming from Trump RX, but
(20:56):
compared to Lily, I mean they're under cutting them by
about you know, hundred dollars at each dose. And this
is basically a ployed to basically compete for new patient starts.
As we know, Lee's got the more effective product in
terms of weight loss profile, and they're also you know,
executing better on the launchers. And I think that's clear
from three Q results where we saw contrasting fortunes between
(21:19):
those two particular drug makers.
Speaker 2 (21:20):
Mikey, give us a sense of this marketplace here, what
percentage of the addressable market is actually taking these obesity
drugs versus because it seems like as the price comes down,
more and more people will be able to get access
to them.
Speaker 9 (21:34):
Yeah. Absolutely, I mean it's a highly priced sensitive market.
When we look at penetration rates in the US, you know,
low single digits, that's obviously going to accelerate as these
drugs become cheaper. Looking outside the US, penetration rates are
even lower, So there's you know, still significant kind of
you know patient runway out there in terms of US penetration.
(21:56):
I mean, the White House pricing deal on GLP one drugs,
you know, supports kind of use of these these GLP
one drugs in medicare you know there we think that
it can unlock you know, seven to eight million patients
according to a White House statement. I think they said
ten percent of Medicare beneficiaries would become eligible for GP
one drugs based on the pilot program, and that's going
(22:19):
to be introduced in twenty six, and I think it's
going to become mandatory in twenty seven. And then they've
also you know, loaded the price in Medicaid too. I
think the uplift in terms of patients there is a
bit harder to deduce or to kind of model, given
that you know, coverage is going to be on a
state by state basis, and there's also kind of different
qualifying criteria, which again is state dependent.
Speaker 3 (22:42):
What does this mean, Michael? For the companies like Hymns
and Hers, the companies that make compounded copycat versions of
these anti obesity drugs, they've done very well. And I
know those stock for Hymns and Hers has been kind
of all over the place, but it is modestly higher
from where it was at the start of the year.
Speaker 9 (22:58):
Yeah, I mean I think that whole well, you know,
the compounding situation. I believe that you know, one point
two million patients from compounding GLP one at the moment.
That's based on kind of comments and Novo made during
their three key results obviously loaning down the price. Would
kind of of the branded treatments would basically well, I
mean it would it would you know, lessen the delta
(23:20):
between you know, coffycats and branded treatment. So I guess
it's a negative for for for these you know, compounded
GLP one drug makers.
Speaker 4 (23:29):
Mikey.
Speaker 2 (23:30):
When I look at the big cap farm of names,
is it as simple as I want to own the
ones with exposure to obesity market and not own the
ones that don't. Because I'm looking at your your slate
of stocks and you either up thirty percent or you're down.
Speaker 9 (23:44):
Yeah, I mean I think you know, there's a there's
a few large farmer names which which has entered the space.
You know, in the in the recent years you've seen
kind of deals with Ross and Zealand for an Amlin drug.
Most recently you've obviously got the fires and met Sarah
an a deal. I mean, I think obesity is obviously
appealing given you know the size of the target population,
(24:06):
how underpenetrated it currently is, and you know, if you're
looking to you know, offset patent expirations later in the decade,
you know there's an abundance of of kind of Jill
point on products out there as well as other assets too.
So I think that's the appeal of the space. It's
a large market, it's underpenetrated, and there's high demand for
these treatments too.
Speaker 3 (24:27):
I mentioned M and A, And of course we know
that JANJ is making a purchase to increase its pipeline
to get away from relying on these older drugs that
have lost patent protection. Is every farmer company doing the
same thing. Is that you know they're not only strategy,
but is that the way they move forward? Is there
anyone who's kind of like in a good position and
(24:47):
doesn't need to make a deal.
Speaker 9 (24:49):
I mean, I think that's always been part of the
large farmer model. They supplement kind of in house innovation
with extern of innovation, particularly if they want to get
into areas perhaps outside of their cool competency. But I mean,
I think that's just that the model in general. Biotechs
always been the pipeline for large farmer companies, or at
least help Bell cault that pipeline.
Speaker 3 (25:11):
Our thanks to Michael shop Bloomberg Intelligence senior pharma biotech
analyst coming up a look at why the global sports
company a Maorsports raised it's full your guidance.
Speaker 2 (25:19):
You're listening to Bloomberg Intelligence on Bloomberg Radio, providing in
depth research and data on two thousand companies and one
hundred and thirty industries.
Speaker 3 (25:25):
You can access Bloomberg Intelligence through Bigo on the terminal.
I'm Scarlett Foe.
Speaker 2 (25:29):
And I'm Paul Sweeney, and this is Bloomberg.
Speaker 1 (25:39):
This is Bloomberg Intelligence with Scarlett Foo and Paul Sweeney
on Bloomberg Radio.
Speaker 2 (25:46):
We move next to earnings from the department store TJX.
Speaker 3 (25:49):
The off price retailer reported third quarter sales that beat
analyst estimates. It also raised its guidance for comparable sales
this year.
Speaker 2 (25:55):
It's a sign that your shoppers are turning to cheaper
options as economy shows signs of d for more. We
were joined by Mary Ross, Gilbert, Bloomberg Intelligence Senior Equity Analyst.
Speaker 3 (26:04):
We began by asking Mary for her take on this
week's results and whether she is a fan of TJX.
Speaker 10 (26:09):
I'm a fan too, and they it's because they carry
such a variety of brands and it appeals to all
income groups. So if you have a luxury consumer, you
can get Balanciaga you can get Chloe low. So they
carry all of the brands. And then if you're more
oppressed and you're really a valued consumer, they have Steve Madden,
(26:31):
they have Theory, so they really they have Puma, they
have Nike, Adidas, so they have all the brands that
consumer want and that's why they're Marmax, which is tj
max and Marshall's division, reported a comp sales increase of
six percent, and that's why. You know, if you look
at the overall results, they were up five percent, so
(26:53):
a lot of strength there within the Marmas home goods
and of course Canada. Canada was up eight So we're
seeing consumers flock to get the brands that they want
and they've had some amazing buying opportunities, so their margins
were higher.
Speaker 3 (27:11):
So the way that TJX stocks at stores is that
they get inventory that hasn't sold at full price stores.
But if all these merchants, all these retailers are managing
their inventories better and don't have a lot of excess inventory,
where does tj X get its inventory. I mean it
has to have another option, right.
Speaker 10 (27:32):
Yeah, Scarlett, you raise a good question, But the fact
is is that some of the retailers, but also the
brands themselves. So if you think of for example, PVH,
which has the Tommy Hill Figure and Calvin Klein brands,
we see those brands pretty prevalent throughout off price. So
that's been a good channel for them to sort of
(27:53):
release some of that excess inventory, and when they work
with some of their wholesale partners, including the department stores,
So were you have product that's not selling off price
is just a natural fit to be able to release
that inventory. So you want to keep your inventory fresh
in the stores, especially when you're a full price operator,
(28:13):
and there hasn't been any slow down in terms of
that excess inventory. And that's why even on the luxury side,
where typically you wouldn't think you'd find markdowns, it's been
pretty prevalent, especially with overall weakness and luxury.
Speaker 2 (28:30):
So what does the folks at Cheak, TJ Max, what
are they saying about the consumer these days?
Speaker 10 (28:36):
Well, the consumer, I mean they're really seeing strength. So
it's interesting because when you sort of read the take
on Target with their results and they sort of cited
you know, the consumer is very cautious, but that caution
I think what's really going on is that they've got
the brands that consumers want. So those that are executing
are the ones that are getting the sales, because even
(28:57):
some retailers that are more full price oriented are generating
sales or they may be promotional, so the consumer is
flocking to value, There's no doubt about it. But we
do see some you know operators. You've got Ralph Lauren
on the luxury side. They continue to outperform and their
sales are always topping expectations too. And consumers there are
(29:19):
willing to pay full price, so there are a lot
less promotional every year. They seem to be less promotional
for that reason, they're able to sell at full price.
Speaker 3 (29:29):
So clearly TJX has a strategy that works well given
the current environment, and even when the economy is doing well,
I would argue it has a strategy that works well.
At what point do investors want more from the company
than just executing on the strategy? Well, they want I
don't know, am an age or do they want consolidation?
Do they want innovation from TJX?
Speaker 10 (29:51):
Yeah, Well, so that's the reason why TGX is focused,
you know, internationally, so they're going to be entering Spain
in twenty twenty six, so coming next year. And of
course they've had some They have two joint venture investments,
one in Mexico and then one in the Middle East,
and they're both off price retailers that they've invested in,
(30:12):
So they're basically taking their talent and providing them a
platform to leverage their talent in these joint ventures and
to grow that way. So they're always looking for ways.
Because Scarlett, you bring up a good point. TJX trades
at a pretty high premium in the off price space,
and generally it's a pretty big premium that is due
(30:32):
to their very consistent execution. But you're right, consumers keep wondering, well,
how can they keep growing on top of all this growth,
and yet they keep doing it. But as they talk about, look,
they have drops several times a week. There's not a
lot of retailers that offer fresh merchandise several times a week,
and they curate the merchandise by location, so they're very
(30:55):
cognizant of the demographics for each location.
Speaker 2 (30:59):
Thanks to Mary Ross Gilt at Bloomberg Intelligence, senior ecody analysts.
Speaker 3 (31:02):
We moved next to news from the Global sports company
a mere Sports.
Speaker 2 (31:05):
This week, the company raised it's for your guidance for
the third time this year. That's after a strong demand
for its Solomon footwear drove quarterly sales to a record.
Speaker 3 (31:13):
Sales growth at the group's other two units, including the
technical apparel segment and the ball and Racket sports unit,
also surpassed estimates, and overall group sales they hit a
new high.
Speaker 2 (31:22):
For more, we were joined by Abigail gil Martin Bloomberg
Intelligence at leisure and footwear analysts on amer sports earnings,
the first to as Abigail to break down amer sports
most recent earnings report.
Speaker 11 (31:33):
They did really well, you know, sales up thirty percent,
broad based strength across regions, across channels, and across brands.
I think the key thing people are looking for was China.
Arctics recently had some controversy in China with fireworks display
in the Himalayas that what fireworks display.
Speaker 2 (31:53):
Displayed fireworks in the Himalayans.
Speaker 11 (31:55):
Arctics for set off fireworks exactly. It was definitely a
misstep for an outdoor brand that's really focused on sustainability,
and there was definitely some concern that there would be
a little backlash in China. There's definitely a lot of
people upset about it, and they were fined by the
Chinese government and working to restore the ecology there. But
(32:17):
Greater China was up forty seven percent, momentum is continuing
into four Q so I think that was really a
big takeaway, just quelling investors' concerns about potential backlash in China,
especially because they're the number one outdoor sports brand in China.
Speaker 3 (32:32):
Arctereric So, I had no idea that they have such
strong brands. I mean, a Mare Sports on its own
is kind of it doesn't it's not memorable the name,
the parent company name, right, but the brands of course
are Solomon, Arctic, so Wilson. As you mentioned, what does
the tariff picture look like for this company.
Speaker 11 (32:49):
Yeah, I think it's very similar to most of the
other companies. I think for them, what benefits them as
their premium positioning. They're able to raise prices and they're
not seeing any from consumers or pullback. They're still seeing
very strong full price sell through, so they're able to
offset some of those tariff costs with that, which I
(33:09):
think is really helping. And we're seeing that with a
lot of more of the premium brands are able to
kind of navigate through the tariffs since their consumers are
willing to pay upper KU, upper.
Speaker 3 (33:18):
K of the K shaped economy.
Speaker 2 (33:20):
I guess I know that's I guess where you want
to be there. Talk to us about the footwear market here.
I think you know, Nike, Adidas, all that kind of stuff.
What's going on there?
Speaker 11 (33:30):
Yeah, I think you know, we're in store for a
very interesting holiday season. I think that we're going to
continue to see the premium brands continue to do well
on holdings. Recently just reported and did phenomenal, and they
also said they're not seeing any backlash on raised prices
and they'll continue to do you know, limited discounting through
the holidays. So we may see some differences between the
(33:52):
two companies, but we just had our recent BI survey
and Nike continues to let I think there's been concerns overnight,
but they still are the major shareholder and still a
favorite brand of millennials. Gen Z's everyone for the holidays,
so they should continue to do well too.
Speaker 3 (34:08):
What is the maorsports distribution strategy? Do they have a
DTC offering or are they going through third party retailers.
Speaker 11 (34:15):
Yeah, that's a great question. So it's a little different
for each brand. For Arctics, they're leaning a lot more
into DTC. They've changed their distribution strategy from basically nine
eighty percent wholesale to eighty percent DTC over the last
three years, and they're really focusing on growing their store
base because I think not a lot of people know
about Arctics. It's really going to help the brand awareness.
(34:37):
So even in the US, they're looking to double their
store account by twenty thirty so that through Solomon continues
to be wholesale, especially for footwear, we're seeing this holiday
season consumers strap for cash.
Speaker 5 (34:51):
They're wanting to.
Speaker 11 (34:52):
Go into the stores and try on their shoes and
make sure it's the right fit and buy them versus
you know, buy five pairs and return them. Yeah, so
the wholesale distribution for Solomon and is really key, and
they're in a lot of key premium partners, I would say,
and you know the running specialty stores as well.
Speaker 2 (35:09):
I mean, I'm looking at your report here research your
reportal on the sneaker business. I didn't know there were
so many shoe manufacturers. I mean, Nike's the dominant one,
as you said, but there's like fourteen in your survey here. Yeah, yeah, No,
that's a competitive marketplace.
Speaker 11 (35:23):
Definitely, it's getting even more competitive as consumers with AI technology,
you know, there's just such more of a breath of discovery.
So that's where product is really coming into play this
holiday season. I think, you know, the innovation, product and style.
Speaker 3 (35:40):
If there's one thing to be worried about when it
comes to amre sports, what would it be? I mean,
what's an area that they're not executing on?
Speaker 11 (35:48):
So I think the China thing was the one uncertainty
for this quarter that we were Definitely it could have
gone either way, so that would be the biggest thing.
But honestly, they're executing on most of their things as
drivers are, DTC, Women's and China and all of those
were up double digits and more. And they're really gaining
share in women's which I think is a big new
(36:09):
opportunity for them as more women joined the outdoor market.
Speaker 2 (36:12):
All right, which have you purchased in the last twelve months?
Sneaker brands for baby boomers? Sketchers?
Speaker 7 (36:20):
Yeah?
Speaker 2 (36:20):
What what Sketches continues to win?
Speaker 5 (36:24):
It is Honestly, they're.
Speaker 11 (36:26):
So comfortable, they're like the price point, the quality. I know,
I know, I know, I know, but.
Speaker 3 (36:33):
This is not something that they market out there, that
they put out there.
Speaker 11 (36:36):
No, and they're the third largest footwear brand globally. Really, yeah,
I think right behind Adidas.
Speaker 3 (36:42):
Next, you're going to tell me that, you know, the
boomers are using the shoes with the little wheel in
the back of.
Speaker 2 (36:46):
The No, the wheelers, the wheels.
Speaker 5 (36:48):
Yeah, No, they're doing the step ins.
Speaker 11 (36:50):
You don't even have to bend down exact it.
Speaker 2 (36:53):
That's what I think it is. I think you're right,
all right, Yeah, there you go. I mean the kids,
the gen z, the millennials, they're still in that Nike.
You yet, brands still audience.
Speaker 11 (37:02):
Or Hokahs, yeah, ka Hoka and on are gaining, but
they're you know, they're still small, and I think people
don't realize that just because there's been such a big boom,
they're still very like West Coast East Coast oriented, you know,
they still have a lot more room to grow brand
awareness in the US, especially in the middle of America.
Speaker 3 (37:20):
That was Abigail Gilbart and Bloomberg Intelligence at Leisure and
Footwear Analysts.
Speaker 2 (37:24):
That's this week's edition of Bloomberg Intelligence on Bloomberg Radio,
providing in depth research and data on two thousand companies
and one hundred and thirty industries.
Speaker 3 (37:30):
And remember you can access Bloomberg Intelligence via b I
go on the terminal. I'm Scarlett Foe and I'm Paul Sweeney.
Speaker 2 (37:36):
Stay with us. Today's top stories and global business headlines
are coming up right now
Bloomberg Audio, Studios, podcasts, radio news. This is Bloomberg Intelligence
with Scarletfoo and Paul Sweeney.
Speaker 2 (00:13):
How do you think the FED is looking at tariffs?
The uncertainty of terriffs.
Speaker 3 (00:17):
Let's take a look at the sectors and how.
Speaker 2 (00:19):
They performed a lot of investors getting whip saled every
day by news events.
Speaker 1 (00:22):
Breaking market headlines and corporate news from across the globe.
Speaker 3 (00:26):
Could we see a market disruption of market events?
Speaker 2 (00:28):
So people just too exuberant out there?
Speaker 3 (00:31):
You see some so called low quality stocks driving this
short term rally.
Speaker 1 (00:34):
Bloomberg Intelligence with Scarletfoo and Paul Sweeney on Bloomberg Radio,
YouTube and Bloomberg Originals.
Speaker 2 (00:42):
On today's Bloomberg Intelligence Show, we dig inside the big
business story is impacting Wall Street and the global markets.
Speaker 3 (00:47):
Each and every week we provide in depth research and
data on some of the two thousand companies and one
hundred and thirty industries are analysts covered worldwide.
Speaker 2 (00:53):
Today, we'll look at earnings reports from some of the
world's largest retailers.
Speaker 3 (00:57):
Plus look at why the Danish drug maker Novo Nordisk
will be further lowering the prices of its obesity drugs
for cash paying patients first.
Speaker 2 (01:03):
We'll begin with earnings from chip Giant and Video.
Speaker 3 (01:06):
This week, the company reported third quarter earnings that topped
analyst estimates, and Vidia also delivered a surprisingly strong revenue
forecast and pushback on the idea that the AI industry
is in a bubble.
Speaker 2 (01:16):
For more, we were joined by Kunjohn Sabani, Bloomberg Intelligence
Senior Semiconductor analyst. We first asked Kunjohn for his take
on in Vidia this week.
Speaker 4 (01:24):
This was one of the more bullish earnings we have
seen from this name in a while, not just on
the numbers of the three Q four Q guide, which
they blew past even the loftiest Byside targets, but just
beyond that the long term the twenty six sort of
and going into twenty seven demands signals that they showed,
namely the half a trillion of the pipeline, which we
(01:46):
think now is a conservative number given the number of
deals they have announced. If supply keeps on coming up
as it has, and if their customers continue executing on
these bills without any missteps, we think their significant upside
to the current numbers.
Speaker 3 (02:01):
Yeah, just looking through the numbers, clearly a beaten Rais report,
but you know, the scale at which it can be
in race is impressive. Although within the third quarter numbers,
I did see that chips used in gaming PCs missed
analess estimates, and I know that that's a shrinking part
of the business, or at least it's not as big
a part of the business, given that the data center
is where the growth is really at. Are there any
(02:24):
flaws in this earnings report? Conjohn?
Speaker 4 (02:26):
Not really? I mean, look, the gaming is becoming so
unimportant for analysts that the reliability of the predictability of
those numbers against which we are comparing the bet and
miss for gaming is no longer as reliable. So no
real flaws to really point out in this. We did
see their supply commitments go up quarter work quarter and
(02:47):
inventory is rising. I don't think that's a negative. While
it might seem on the face that's just them getting
up and getting ready for that next wave to supply
the chips in the next year.
Speaker 2 (02:57):
So could John what's the latest and Gentin want about
how he've used China going forward?
Speaker 4 (03:03):
Nothing has changed on the China side. They still don't
assume any revenues when it comes to data center AI
China GPUs or the H twenty has been shipped into
They do have the clearance licenses so they could, but
it seems because of the geopolitical issues, China has basically
been shut down for American GPU providers or AC providers
to be able to ship in the country. There isn't,
(03:25):
to be honest, no demand. So it seems, you know,
because of geopolitical issues, the customers in China are not
just reading and getting up to buy in media chips
right now.
Speaker 3 (03:34):
Jensenhang said that he from his vantage point, does not
see anything like an AI bubble. We see something very different,
and he says competitive pressures remain fairly low because this
is a company with more than ninety percent of the
market for those high end super fast AI chips. Who
is the closest competitor if there is one t Invidia.
Speaker 4 (03:55):
Yeah, in terms of the size of the markets, the
next closest competitor would be the AIA six chips, So
Broadcome is one of the biggest providers of AI six chips,
namely the TPU that Google uses. Another example would be
Amazon's Treanium chips, which are on different AI asic designers supply.
So in terms of revenues, or units in terms of
(04:16):
the market that those are the next closest competitors within
Nvidia's realm, which it sells merchant gipus, AMD would be
the second closest competitor in that our Thanks.
Speaker 3 (04:26):
To Kunjan Sabani, Bloomberg Intelligence Senior semiconductor analyst.
Speaker 2 (04:29):
We continue in the tech space.
Speaker 3 (04:31):
This week we heard that the tech giants Microsoft and
Nvidia are committing to invest up to a combined fifteen
billion dollars in the AI research and development company Anthropic.
Speaker 2 (04:40):
We heard the investment will be part of anthropics next
funding round. The companies also said Anthropic has committed to
purchase thirty billion dollars of computing capacity for Microsoft's Azure
cloud service.
Speaker 3 (04:50):
So of course we had to enlist. Mandeep Singh, global
tech research head at Bloomberg Intelligence.
Speaker 2 (04:55):
First asked man Deep to tell us a little more
about Anthropic and what it does well.
Speaker 5 (04:59):
Anthropic is one of the five frontier lms that are remaining,
I mean, and they are leading the charge when it
comes to generative AI. So it's one of the five.
The other one are Google, Open Ai, Meta and XAI.
And so look, when it comes to these commitments, it's
(05:19):
pretty obvious that open Ai has raised the bar by
announcing they're going to spend one point four trillion. So
the question is what are the other LLM companies going
to do? And Entropic is also a pure play LLLM,
and in their case, they don't have the funding. I mean,
they don't have the balance sheet like Google or Meta have,
(05:40):
so they have to raise the money either in the
private markets or from someone like Nvidia, or get into
an agreement with Microsoft, which also has an agreement with
open Ai. So that's where you know. Llms need compute.
That's how you serve billion plus users, and that's where
you know the numbers get bigger and bigger when it
(06:02):
comes to the tie ups with cloud provider.
Speaker 3 (06:04):
This is like the popular click in high school, where
everyone knows each other and everyone's messing around with each other.
Just give us a little bit of background here on Anthropic,
because my understanding is that it was founded by folks
who used to work at open Ai and some of
the early investors like big stakeholders include Alphabet and include
Amazon and now you've got Microsoft in there. I mean,
(06:27):
is there anyone who's not part of Anthropic and not
committed to investing in this company.
Speaker 5 (06:32):
Well, you could say Meta, they're doing things.
Speaker 3 (06:36):
They're doing their own thing.
Speaker 5 (06:37):
They are doing their own thing in terms of, you know,
using the computer internally, and they don't have a cloud business.
Speaker 3 (06:44):
Is that a problem for them that Meta's out there
on its own I know, it doesn't have its own
cloud business, but it's not buying stakes or committed to
invest up to five billion or ten billion in any
of these AI companies.
Speaker 5 (06:55):
I mean so far, just to go to Meta, it
feels like, you know, investors were okay with them using
the GPU compute for their own family of apps. But
the fact that they're talking about one hundred billion plus
in capex for next year without having a substantial ROI
and what I mean by rois in the case of Microsoft,
(07:15):
yes they're raising their CAPEX two hundred and twenty billion,
but they're winning deals like the one with Nthropic thirty
billion dollar in commitment from Entropic, so somebody is paying
for that compute. In the case of Microsoft, you don't
have that with a Meta. How are you generating ROI
outside of your family of apps? And over there you
(07:36):
have to show a really substantial increase in engagement to
convince investors it's worth hundred billion plus in capex.
Speaker 2 (07:43):
Any of these open aies anthropics, are they going to
ever come public? Do you think?
Speaker 5 (07:49):
I mean, in the case of Entropic, look, I know
the numbers are getting big, but their gross margins at
this point are probably better than open AI, which is
doing too much any things. I mean, the biggest risk
I see for Opening Eyes they feel they can get
into any business, whether it's chip business, whether it's you know,
(08:09):
obviously LLLM is their turf, any type of applications, and
that's where there's a possibility of a misstep. You can
end up wasting time because you just don't have, uh,
you know, the capability. Yeah, the focus Entropic is more.
Speaker 3 (08:23):
Focused our thanks Toman deep saying, global tech research head
at Bloomberg Intelligence.
Speaker 2 (08:28):
We move next to some earnings from some of the
world's largest retailers.
Speaker 1 (08:31):
This week.
Speaker 3 (08:32):
Target posted a drop in third quarter sales due to
intense competition and a weakening economy, with shoppers pulling back
on apparel and home goods.
Speaker 2 (08:39):
Separately, Walmart reported third quarter earnings that beat analysts expectations.
The retailer also increased its outlook for sales in the
full year. It's a sign Walmart is winning over priced
sensitive shoppers while digesting costs it expects to rise in
the coming months.
Speaker 3 (08:53):
For more, we were joined by Jennifer bartashis Bloomberg Intelligence
senior analysts covering retail staples and packaged foods.
Speaker 2 (08:58):
First test jenf for her take on the most recent
results at Walmart.
Speaker 6 (09:02):
You know, Walmart had another good quarter, and I think
that it's very easy to attribute a lot of their
success to just the value seeking behavior of consumers in
this environment. But I think that would also be overlooking
a lot of the investments they've made in things like
convenience that is really spurring the e commerce growth. And
that was really a notable takeaway.
Speaker 3 (09:20):
Yeah, that e commerce aspect helps draw on higher income shoppers,
so it's a larger pool of customers at Walmart now
has access to and in our Bloomberg News reporting we
indicate that the digital offerings now include luxury items like
pre owned Chanel bags. I had no idea that that
kind of stuff was available on walmart dot com.
Speaker 6 (09:39):
Well, you know, Walmart has done a lot to really
expand its marketplace, and that includes bringing in items that
you know, will appeal to that higher income consumer, you know,
And the tactic behind all of this is that the
more people are integrated with e commerce in going to stores,
they become sticky and they become loyal customers, so that
when the macre can comic backdrop fades, it really increases
(10:02):
Walmart's ability to hang onto these customers going forward, and
that just drives future growth. So it's a really interesting
play out of how they're applying that tactic.
Speaker 3 (10:11):
Jen, I also want to get your take on Walmart transferring.
It's listing to the NASAC that's going to happen on
December ninth, and that of course is to reflect as
focus on being a tech forward company. But I'm wondering,
I mean, how much of this is really just about
being included in the Nazak one hundred and therefore the
qqq etl Oh.
Speaker 6 (10:30):
Yeah, there's certainly part of that scarlet where you know,
that's that's probably part of the motivation. I think that
there is. You know, obviously there's a perception with regards
to being perceived more as a tech company, which Walmart
in all truthfulness, has evolved into a tech company, especially
amongst other retailers. By being listed at NASDAK, you know,
(10:51):
long term, maybe it helps their valuation, you know, just
in terms of having that perception of being more you know,
aligned with peers. You know, Amazon listed on Nasdaq, things
like that. So I think that there's a lot of
those components together combined, are really behind the move.
Speaker 2 (11:08):
Jen nobody arguably has a better finger on the pulse
of the consumer than Walmart. What are they saying these days?
Speaker 6 (11:14):
Actually, they seem relatively optimistic. You know, they talk about
you know, spending, holding study for kind of that middle
income consumer, high end consumer seemed to be spending pretty freely,
a little bit of concern about some of the lower
end consumer, but it does seem to be sort of
evening out. And so when they were looking forward to
the holiday season, which is you know, the most important
(11:35):
thing with regards to the retailers that I cover, they
seem cautiously optimistic that there will be a pretty good
holiday season this year. We do think that they're going
to people will prioritize spending on kids. That's usually what
happens first if they're holding back in other parts of
their budget. But all indicators right now seem that we're
headed towards a reasonably solid holiday season.
Speaker 3 (11:56):
Are thanks to Jennifer Bartash's Bloomberg Intelligence senior analysts covering retail,
staples and packaged food. Coming up, we'll take a look
at why the global payments services provider Klarna reported record
revenue in its first quarter since going public.
Speaker 2 (12:08):
You're listening to Bloomberg Intelligence on Bloomberg Radio, providing in
depth research and data on two thousand companies and one
hundred and thirty industries.
Speaker 3 (12:14):
You can access Bloomberg Intelligence via Bigo on the terminal.
I'm Scarlet Foo and.
Speaker 2 (12:18):
I'm Paul Sweeney, and this is Bloomberg.
Speaker 1 (12:24):
This is Bloomberg Intelligence with Scarlet Foo and Paul Sweeney
on Bloomberg Radio.
Speaker 2 (12:31):
We move next to earnings from some of the world's
largest home improvement retailers.
Speaker 3 (12:35):
This week, Low's reported third quarter profit that topped analyst estimates.
This was a result of online sales and demand from
professional contractors.
Speaker 2 (12:42):
Separately, we heard from Home Depot, who cut its full
of your guidance. This come as a company warned that
some unsteady consumers are hitting the pause button on big
ticket home purchases.
Speaker 3 (12:50):
So we spoke with Drew Redding Bloomberg Intelligence US home
building analyst.
Speaker 2 (12:54):
We first Saske Drew to break down this week's results
from Low's and how they compare it to Home Depots.
Speaker 7 (12:58):
So, I think Loew's result could be best characterized as
better than feared, particularly in light of what we heard
from Home Depot. They did fall short of consensus estimates
on same store sales, but I think the buy side
was probably looking for something flat to lower, so a
little bit better than they were looking for. Now that
being said, they did trim their four year outlook. Now
(13:21):
they're looking for four year comp sales to be flat
from flat to up one percent, So that would imply
that four Q is relatively flat. But you know, similar
to what we heard from Home Depot, they had about
one hundred basis point impact from hurricane activity that was
not replicated this year. So again, if you were to
back that out, it looks like the underlying trends in
the business are pretty stable.
Speaker 5 (13:43):
You know.
Speaker 7 (13:43):
That being said, they're still grappling with the same consumer
uncertainty and you know, the same weak housing market that
their competitors, so you know, still challenges out there in
the market.
Speaker 2 (13:53):
Drew, I think I understand it. Correctly that Lows has
a lower percentage of sales to professional contractors than does
Home Depot If so, are they trying to narrow the gap?
Are they targeting that segment a little more?
Speaker 7 (14:05):
Yeah, great question. So Low's is about thirty percent professional
contractors seventy percent DIY. Home Depot is about fifty to
fifty maybe even a little bit higher on the pro front.
What's interesting, and to your point on investment, is the
pro space, especially in building products distribution, has really become
a battleground among home improvement retailers. You had Home Depot
(14:28):
recently do acquisitions for srs and gms, and then you
have Lows who recently acquired foundation building materials, So it's
certainly an area where they're making a concerted effort to grow. Now.
Lows has historically focused on the small and medium sized
pro and what this acquisition does is it gives them
(14:48):
exposure to larger pros who do more complex projects, so
they're able to be the supplier of choice across more
building product categories and at a larger scale.
Speaker 3 (15:00):
So basically directly competing with Home DEEPO in many ways.
Is this going to become a duopoly or are there's
still a lot of other places that professional contractors can
go to.
Speaker 7 (15:10):
Yeah, so the building products distribution space is still very
highly fragmented, you know, I wouldn't be surprised to see
further consolidation within the industry, you know, across different categories.
Home Depot and Lows are certainly, you know, two of
the behemoths in the industry who have, you know, the
scale and financial flexibility to further consolidate the industry. But
(15:31):
there's some other players as well, like QXO. So it
is a mented industry, but I would expect, you know,
in the coming years, it's something that continues to get consolidated.
Speaker 2 (15:41):
I can't keep track of where all the tariffs are
these days on all the different products, but I'm just
guessing if I'm a Low's or Home Depot, my plywood
from Canada that's probably being tariff A power tool from
somewhere in Asia that's probably subject to tariff's. How are
these companies dealing with it? What have they been telling
you guys?
Speaker 7 (15:58):
So, Lows gets about sixty percent of its products from
the US, so their exposure internationally is maybe not as
high as you would expect. China's probably around fifteen to
twenty percent. You know, there hasn't been a whole lot
of talk. I think we have seen their average ticket
increase this quarter was up about three percent, and part
of that is in response to tariff related price increases.
(16:19):
Loose told us that they were only modest increases, and
you know, they'll take a portfolio approach to how they
increase prices. They'll look at their product line up and
see where they have more elasticity. But I think the
impact of costs will start to come in a little
greater as we look into Q four in early twenty
twenty six. And you know some of the areas that
we're looking at. You mentioned plywood so lumber tariffs from Canada.
(16:41):
We also had the implementation of tariffs on cabinetry both
the kitchen and bath, which to go up to fifty
percent in January. So I do think that the impact
gets a little greater as we look at the next year.
So I would expect further price increases from both retailers.
Speaker 3 (16:56):
Are Thanks to Drew Reading Bloomberg Intelligence, US home building analyst.
Speaker 2 (16:59):
We've moved to third quarter earnings from the global payment
services provider Klina this week.
Speaker 3 (17:04):
Kliner reported record revenue that beat analysts estimates on Wall Street.
The firm also set aside more provisions for credit losses
in its first set of earnings since going public.
Speaker 2 (17:12):
For more, I was joined by Anthony Hughes, Bloomberg Equity
Capital Markets reporter. I first asked Anthony to talk to
us about Cliner's most recent results.
Speaker 8 (17:20):
Yeah, Well, klan is a company that's actually been around
for about two decades. It's just that since about twenty
and nineteen they've really expanded quickly in.
Speaker 2 (17:28):
The US and by now.
Speaker 8 (17:29):
Pay Later is a lending slash payments product which basically
allows people to buy products and obviously pay for them
over time. And this is an alternative to the credit
card in a credit card option. So really a lot
of Klana's growth really reflects the fact that this product's
becoming more popular relative to credit cards and for a
(17:50):
lot of consumers, it's a good way to manage your
cash flow and you know, obviously buy a product and
not have to pay for over time, and that suits
a lot of people, and it is a fast growing
part of the fintech or say consumer lending space.
Speaker 2 (18:02):
And as a consumer, how does Clorina make money on
my one hundred dollars purchase that they put on their system. Yeah,
well they trudge me interest.
Speaker 8 (18:12):
No, well, this number of different products that some of
the longer term lending products do have interests associated with them.
But that paying for product they talk about, which is
paying in four installments over a few months, that is
an interest free product. And really the source of revenue
in this in that instance is from the merchant, and
merchants pay merchant service fee. It's high for them, it's
(18:32):
higher than they pay on a credit card transaction. But
basically they see the benefit of Klana bringing in extra
customers so they can sell more product. And you know,
people will ask themselves, well, who actually pays the merchant
service fee? While the merchant does pay that to Klana,
but the merchant does incorporate that as a cost of
doing business into the products that these sells to you
and I. So we in the sense we all pay
(18:55):
for the fees that are hidden within the payment system
and really merchants passed on to the consumer depending on
how you pay the interesting you pay for.
Speaker 2 (19:05):
Your who's a typical Klarner consumer out there? Like what
what's and what's kind of a typical transaction for a
buy nine.
Speaker 8 (19:12):
Yeah, well, these are mainly small transactions of you know,
can be a few hundred dollars or you know, not
not not large transactions. And and you know, this obviously
suits a younger audience, and that's where a lot of
the you know, a lot of their customer bases come from.
But they've built a large business which globally has something
like one hundred and ten billion of what they call
(19:33):
gross merchandise volume, and that's you know, it's a fast
growing business in the US. It's been growing pretty fast
for them, forty fifty percent in this recent quarter. And
obviously there's a couple of other companies that are in
this area as well, so it's a competitive area as well,
with a firm which is another company went public perhaps
about five years ago.
Speaker 3 (19:51):
That was Anthony Hughes, Bloomberg Equity Capital Markets Reporter.
Speaker 2 (19:54):
We moved to some news in the biotech space this week.
Speaker 3 (19:57):
We heard that the Danish drug maker Novo Nordesk will
be further lowering the prices of its obesity drugs for
cash paying patients.
Speaker 2 (20:03):
It's in an effort to call back a larger share
of the US market from arch rival Eli Lilly. Nova
said introductory doses of its blockbuster drugs we Govi and
ozembic will be available for one hundred and ninety nine
dollars a month.
Speaker 3 (20:15):
That price applies to the first two months of treatment.
After that, Nova will offer the drugs through its Novocare
direct to consumer portal for three hundred and forty nine
dollars a month, that is thirty percent less than the
current self pay price.
Speaker 2 (20:26):
For more, we were joined by Michael Shaw, Bloomberg Intelligence
Senior pharma biotech analyst. Well first asked Michael to break
down what exactly Nova nord Disk is doing.
Speaker 9 (20:35):
And this is obviously ahead of the White House tales.
So you're seeing starting dice is being reduced two hundred
dollars per month and then doses thereafter being charged at
an average of three hundred and fifty dollars per month
compared to five hundred dollars previously. So, I mean, you know,
those prices kind of align to, you know, the pricing
in the White House statement coming from Trump RX, but
(20:56):
compared to Lily, I mean they're under cutting them by
about you know, hundred dollars at each dose. And this
is basically a ployed to basically compete for new patient starts.
As we know, Lee's got the more effective product in
terms of weight loss profile, and they're also you know,
executing better on the launchers. And I think that's clear
from three Q results where we saw contrasting fortunes between
(21:19):
those two particular drug makers.
Speaker 2 (21:20):
Mikey, give us a sense of this marketplace here, what
percentage of the addressable market is actually taking these obesity
drugs versus because it seems like as the price comes down,
more and more people will be able to get access
to them.
Speaker 9 (21:34):
Yeah. Absolutely, I mean it's a highly priced sensitive market.
When we look at penetration rates in the US, you know,
low single digits, that's obviously going to accelerate as these
drugs become cheaper. Looking outside the US, penetration rates are
even lower, So there's you know, still significant kind of
you know patient runway out there in terms of US penetration.
(21:56):
I mean, the White House pricing deal on GLP one drugs,
you know, supports kind of use of these these GLP
one drugs in medicare you know there we think that
it can unlock you know, seven to eight million patients
according to a White House statement. I think they said
ten percent of Medicare beneficiaries would become eligible for GP
one drugs based on the pilot program, and that's going
(22:19):
to be introduced in twenty six, and I think it's
going to become mandatory in twenty seven. And then they've
also you know, loaded the price in Medicaid too. I
think the uplift in terms of patients there is a
bit harder to deduce or to kind of model, given
that you know, coverage is going to be on a
state by state basis, and there's also kind of different
qualifying criteria, which again is state dependent.
Speaker 3 (22:42):
What does this mean, Michael? For the companies like Hymns
and Hers, the companies that make compounded copycat versions of
these anti obesity drugs, they've done very well. And I
know those stock for Hymns and Hers has been kind
of all over the place, but it is modestly higher
from where it was at the start of the year.
Speaker 9 (22:58):
Yeah, I mean I think that whole well, you know,
the compounding situation. I believe that you know, one point
two million patients from compounding GLP one at the moment.
That's based on kind of comments and Novo made during
their three key results obviously loaning down the price. Would
kind of of the branded treatments would basically well, I
mean it would it would you know, lessen the delta
(23:20):
between you know, coffycats and branded treatment. So I guess
it's a negative for for for these you know, compounded
GLP one drug makers.
Speaker 4 (23:29):
Mikey.
Speaker 2 (23:30):
When I look at the big cap farm of names,
is it as simple as I want to own the
ones with exposure to obesity market and not own the
ones that don't. Because I'm looking at your your slate
of stocks and you either up thirty percent or you're down.
Speaker 9 (23:44):
Yeah, I mean I think you know, there's a there's
a few large farmer names which which has entered the space.
You know, in the in the recent years you've seen
kind of deals with Ross and Zealand for an Amlin drug.
Most recently you've obviously got the fires and met Sarah
an a deal. I mean, I think obesity is obviously
appealing given you know the size of the target population,
(24:06):
how underpenetrated it currently is, and you know, if you're
looking to you know, offset patent expirations later in the decade,
you know there's an abundance of of kind of Jill
point on products out there as well as other assets too.
So I think that's the appeal of the space. It's
a large market, it's underpenetrated, and there's high demand for
these treatments too.
Speaker 3 (24:27):
I mentioned M and A, And of course we know
that JANJ is making a purchase to increase its pipeline
to get away from relying on these older drugs that
have lost patent protection. Is every farmer company doing the
same thing. Is that you know they're not only strategy,
but is that the way they move forward? Is there
anyone who's kind of like in a good position and
(24:47):
doesn't need to make a deal.
Speaker 9 (24:49):
I mean, I think that's always been part of the
large farmer model. They supplement kind of in house innovation
with extern of innovation, particularly if they want to get
into areas perhaps outside of their cool competency. But I mean,
I think that's just that the model in general. Biotechs
always been the pipeline for large farmer companies, or at
least help Bell cault that pipeline.
Speaker 3 (25:11):
Our thanks to Michael shop Bloomberg Intelligence senior pharma biotech
analyst coming up a look at why the global sports
company a Maorsports raised it's full your guidance.
Speaker 2 (25:19):
You're listening to Bloomberg Intelligence on Bloomberg Radio, providing in
depth research and data on two thousand companies and one
hundred and thirty industries.
Speaker 3 (25:25):
You can access Bloomberg Intelligence through Bigo on the terminal.
I'm Scarlett Foe.
Speaker 2 (25:29):
And I'm Paul Sweeney, and this is Bloomberg.
Speaker 1 (25:39):
This is Bloomberg Intelligence with Scarlett Foo and Paul Sweeney
on Bloomberg Radio.
Speaker 2 (25:46):
We move next to earnings from the department store TJX.
Speaker 3 (25:49):
The off price retailer reported third quarter sales that beat
analyst estimates. It also raised its guidance for comparable sales
this year.
Speaker 2 (25:55):
It's a sign that your shoppers are turning to cheaper
options as economy shows signs of d for more. We
were joined by Mary Ross, Gilbert, Bloomberg Intelligence Senior Equity Analyst.
Speaker 3 (26:04):
We began by asking Mary for her take on this
week's results and whether she is a fan of TJX.
Speaker 10 (26:09):
I'm a fan too, and they it's because they carry
such a variety of brands and it appeals to all
income groups. So if you have a luxury consumer, you
can get Balanciaga you can get Chloe low. So they
carry all of the brands. And then if you're more
oppressed and you're really a valued consumer, they have Steve Madden,
(26:31):
they have Theory, so they really they have Puma, they
have Nike, Adidas, so they have all the brands that
consumer want and that's why they're Marmax, which is tj
max and Marshall's division, reported a comp sales increase of
six percent, and that's why. You know, if you look
at the overall results, they were up five percent, so
(26:53):
a lot of strength there within the Marmas home goods
and of course Canada. Canada was up eight So we're
seeing consumers flock to get the brands that they want
and they've had some amazing buying opportunities, so their margins
were higher.
Speaker 3 (27:11):
So the way that TJX stocks at stores is that
they get inventory that hasn't sold at full price stores.
But if all these merchants, all these retailers are managing
their inventories better and don't have a lot of excess inventory,
where does tj X get its inventory. I mean it
has to have another option, right.
Speaker 10 (27:32):
Yeah, Scarlett, you raise a good question, But the fact
is is that some of the retailers, but also the
brands themselves. So if you think of for example, PVH,
which has the Tommy Hill Figure and Calvin Klein brands,
we see those brands pretty prevalent throughout off price. So
that's been a good channel for them to sort of
(27:53):
release some of that excess inventory, and when they work
with some of their wholesale partners, including the department stores,
So were you have product that's not selling off price
is just a natural fit to be able to release
that inventory. So you want to keep your inventory fresh
in the stores, especially when you're a full price operator,
(28:13):
and there hasn't been any slow down in terms of
that excess inventory. And that's why even on the luxury side,
where typically you wouldn't think you'd find markdowns, it's been
pretty prevalent, especially with overall weakness and luxury.
Speaker 2 (28:30):
So what does the folks at Cheak, TJ Max, what
are they saying about the consumer these days?
Speaker 10 (28:36):
Well, the consumer, I mean they're really seeing strength. So
it's interesting because when you sort of read the take
on Target with their results and they sort of cited
you know, the consumer is very cautious, but that caution
I think what's really going on is that they've got
the brands that consumers want. So those that are executing
are the ones that are getting the sales, because even
(28:57):
some retailers that are more full price oriented are generating
sales or they may be promotional, so the consumer is
flocking to value, There's no doubt about it. But we
do see some you know operators. You've got Ralph Lauren
on the luxury side. They continue to outperform and their
sales are always topping expectations too. And consumers there are
(29:19):
willing to pay full price, so there are a lot
less promotional every year. They seem to be less promotional
for that reason, they're able to sell at full price.
Speaker 3 (29:29):
So clearly TJX has a strategy that works well given
the current environment, and even when the economy is doing well,
I would argue it has a strategy that works well.
At what point do investors want more from the company
than just executing on the strategy? Well, they want I
don't know, am an age or do they want consolidation?
Do they want innovation from TJX?
Speaker 10 (29:51):
Yeah, Well, so that's the reason why TGX is focused,
you know, internationally, so they're going to be entering Spain
in twenty twenty six, so coming next year. And of
course they've had some They have two joint venture investments,
one in Mexico and then one in the Middle East,
and they're both off price retailers that they've invested in,
(30:12):
So they're basically taking their talent and providing them a
platform to leverage their talent in these joint ventures and
to grow that way. So they're always looking for ways.
Because Scarlett, you bring up a good point. TJX trades
at a pretty high premium in the off price space,
and generally it's a pretty big premium that is due
(30:32):
to their very consistent execution. But you're right, consumers keep wondering, well,
how can they keep growing on top of all this growth,
and yet they keep doing it. But as they talk about, look,
they have drops several times a week. There's not a
lot of retailers that offer fresh merchandise several times a week,
and they curate the merchandise by location, so they're very
(30:55):
cognizant of the demographics for each location.
Speaker 2 (30:59):
Thanks to Mary Ross Gilt at Bloomberg Intelligence, senior ecody analysts.
Speaker 3 (31:02):
We moved next to news from the Global sports company
a mere Sports.
Speaker 2 (31:05):
This week, the company raised it's for your guidance for
the third time this year. That's after a strong demand
for its Solomon footwear drove quarterly sales to a record.
Speaker 3 (31:13):
Sales growth at the group's other two units, including the
technical apparel segment and the ball and Racket sports unit,
also surpassed estimates, and overall group sales they hit a
new high.
Speaker 2 (31:22):
For more, we were joined by Abigail gil Martin Bloomberg
Intelligence at leisure and footwear analysts on amer sports earnings,
the first to as Abigail to break down amer sports
most recent earnings report.
Speaker 11 (31:33):
They did really well, you know, sales up thirty percent,
broad based strength across regions, across channels, and across brands.
I think the key thing people are looking for was China.
Arctics recently had some controversy in China with fireworks display
in the Himalayas that what fireworks display.
Speaker 2 (31:53):
Displayed fireworks in the Himalayans.
Speaker 11 (31:55):
Arctics for set off fireworks exactly. It was definitely a
misstep for an outdoor brand that's really focused on sustainability,
and there was definitely some concern that there would be
a little backlash in China. There's definitely a lot of
people upset about it, and they were fined by the
Chinese government and working to restore the ecology there. But
(32:17):
Greater China was up forty seven percent, momentum is continuing
into four Q so I think that was really a
big takeaway, just quelling investors' concerns about potential backlash in China,
especially because they're the number one outdoor sports brand in China.
Speaker 3 (32:32):
Arctereric So, I had no idea that they have such
strong brands. I mean, a Mare Sports on its own
is kind of it doesn't it's not memorable the name,
the parent company name, right, but the brands of course
are Solomon, Arctic, so Wilson. As you mentioned, what does
the tariff picture look like for this company.
Speaker 11 (32:49):
Yeah, I think it's very similar to most of the
other companies. I think for them, what benefits them as
their premium positioning. They're able to raise prices and they're
not seeing any from consumers or pullback. They're still seeing
very strong full price sell through, so they're able to
offset some of those tariff costs with that, which I
(33:09):
think is really helping. And we're seeing that with a
lot of more of the premium brands are able to
kind of navigate through the tariffs since their consumers are
willing to pay upper KU, upper.
Speaker 3 (33:18):
K of the K shaped economy.
Speaker 2 (33:20):
I guess I know that's I guess where you want
to be there. Talk to us about the footwear market here.
I think you know, Nike, Adidas, all that kind of stuff.
What's going on there?
Speaker 11 (33:30):
Yeah, I think you know, we're in store for a
very interesting holiday season. I think that we're going to
continue to see the premium brands continue to do well
on holdings. Recently just reported and did phenomenal, and they
also said they're not seeing any backlash on raised prices
and they'll continue to do you know, limited discounting through
the holidays. So we may see some differences between the
(33:52):
two companies, but we just had our recent BI survey
and Nike continues to let I think there's been concerns overnight,
but they still are the major shareholder and still a
favorite brand of millennials. Gen Z's everyone for the holidays,
so they should continue to do well too.
Speaker 3 (34:08):
What is the maorsports distribution strategy? Do they have a
DTC offering or are they going through third party retailers.
Speaker 11 (34:15):
Yeah, that's a great question. So it's a little different
for each brand. For Arctics, they're leaning a lot more
into DTC. They've changed their distribution strategy from basically nine
eighty percent wholesale to eighty percent DTC over the last
three years, and they're really focusing on growing their store
base because I think not a lot of people know
about Arctics. It's really going to help the brand awareness.
(34:37):
So even in the US, they're looking to double their
store account by twenty thirty so that through Solomon continues
to be wholesale, especially for footwear, we're seeing this holiday
season consumers strap for cash.
Speaker 5 (34:51):
They're wanting to.
Speaker 11 (34:52):
Go into the stores and try on their shoes and
make sure it's the right fit and buy them versus
you know, buy five pairs and return them. Yeah, so
the wholesale distribution for Solomon and is really key, and
they're in a lot of key premium partners, I would say,
and you know the running specialty stores as well.
Speaker 2 (35:09):
I mean, I'm looking at your report here research your
reportal on the sneaker business. I didn't know there were
so many shoe manufacturers. I mean, Nike's the dominant one,
as you said, but there's like fourteen in your survey here. Yeah, yeah, No,
that's a competitive marketplace.
Speaker 11 (35:23):
Definitely, it's getting even more competitive as consumers with AI technology,
you know, there's just such more of a breath of discovery.
So that's where product is really coming into play this
holiday season. I think, you know, the innovation, product and style.
Speaker 3 (35:40):
If there's one thing to be worried about when it
comes to amre sports, what would it be? I mean,
what's an area that they're not executing on?
Speaker 11 (35:48):
So I think the China thing was the one uncertainty
for this quarter that we were Definitely it could have
gone either way, so that would be the biggest thing.
But honestly, they're executing on most of their things as
drivers are, DTC, Women's and China and all of those
were up double digits and more. And they're really gaining
share in women's which I think is a big new
(36:09):
opportunity for them as more women joined the outdoor market.
Speaker 2 (36:12):
All right, which have you purchased in the last twelve months?
Sneaker brands for baby boomers? Sketchers?
Speaker 7 (36:20):
Yeah?
Speaker 2 (36:20):
What what Sketches continues to win?
Speaker 5 (36:24):
It is Honestly, they're.
Speaker 11 (36:26):
So comfortable, they're like the price point, the quality. I know,
I know, I know, I know, but.
Speaker 3 (36:33):
This is not something that they market out there, that
they put out there.
Speaker 11 (36:36):
No, and they're the third largest footwear brand globally. Really, yeah,
I think right behind Adidas.
Speaker 3 (36:42):
Next, you're going to tell me that, you know, the
boomers are using the shoes with the little wheel in
the back of.
Speaker 2 (36:46):
The No, the wheelers, the wheels.
Speaker 5 (36:48):
Yeah, No, they're doing the step ins.
Speaker 11 (36:50):
You don't even have to bend down exact it.
Speaker 2 (36:53):
That's what I think it is. I think you're right,
all right, Yeah, there you go. I mean the kids,
the gen z, the millennials, they're still in that Nike.
You yet, brands still audience.
Speaker 11 (37:02):
Or Hokahs, yeah, ka Hoka and on are gaining, but
they're you know, they're still small, and I think people
don't realize that just because there's been such a big boom,
they're still very like West Coast East Coast oriented, you know,
they still have a lot more room to grow brand
awareness in the US, especially in the middle of America.
Speaker 3 (37:20):
That was Abigail Gilbart and Bloomberg Intelligence at Leisure and
Footwear Analysts.
Speaker 2 (37:24):
That's this week's edition of Bloomberg Intelligence on Bloomberg Radio,
providing in depth research and data on two thousand companies
and one hundred and thirty industries.
Speaker 3 (37:30):
And remember you can access Bloomberg Intelligence via b I
go on the terminal. I'm Scarlett Foe and I'm Paul Sweeney.
Speaker 2 (37:36):
Stay with us. Today's top stories and global business headlines
are coming up right now
Popular Podcasts
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Are You A Charlotte?
In 1997, actress Kristin Davis’ life was forever changed when she took on the role of Charlotte York in Sex and the City. As we watched Carrie, Samantha, Miranda and Charlotte navigate relationships in NYC, the show helped push once unacceptable conversation topics out of the shadows and altered the narrative around women and sex. We all saw ourselves in them as they searched for fulfillment in life, sex and friendships. Now, Kristin Davis wants to connect with you, the fans, and share untold stories and all the behind the scenes. Together, with Kristin and special guests, what will begin with Sex and the City will evolve into talks about themes that are still so relevant today. "Are you a Charlotte?" is much more than just rewatching this beloved show, it brings the past and the present together as we talk with heart, humor and of course some optimism.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.